Design, Synthesis, and Biological Evaluation of 1,2,4-Thiadiazole-1,2,4-Triazole Derivatives Bearing Amide Functionality As Anticancer Agents

Overview

Journal Arab J Sci Eng

Publisher Springer

Date 2020 Aug 25

PMID 32837812

Citations 7

Authors

Yazala Jyothsna Pragathi

Reddymasu Sreenivasulu

Deekala Veronica

Rudraraju Ramesh Raju

Affiliations

Soon will be listed here.

Abstract

A novel library of amide functionality having 1,2,4-thiadiazole-1,2,4-triazole () analogs was designed, synthesized, and structures were characterized by H NMR, C NMR, and mass (ESI-MS) spectral data. Further, all compounds were evaluated for their anticancer activities against four different cancer cell lines including breast cancer (MCF-7, MDA MB-231), lung cancer (A549), and prostate cancer (DU-145) by MTT reduction assay method, and etoposide acts as a standard drug. The results confirmed that majority of the synthesized compounds showed moderate to potent anticancer activities aligned with four cell lines. Among the synthesized compounds, and displayed more potent activity along with inhibitory concentration values ranging from 0.10 ± 0.084 to 11.5 ± 6.49 µM than the standard IC values, which ranges from 1.91 ± 0.84 to 3.08 ± 0.135 µM, respectively.

Citing Articles

Anticancer Activity of Ether Derivatives of Chrysin.

Sokal A, Mruczek P, Niedoba M, Dewalska A, Stocerz K, Kadela-Tomanek M Molecules. 2025; 30(4).

PMID: 40005270 PMC: 11857933. DOI: 10.3390/molecules30040960.

Discovery of Novel and Selective Schiff Base Inhibitors as a Key for Drug Synthesis, Molecular Docking, and Pharmacological Evaluation.

Khan I, Rehman W, Rasheed L, Rahim F, Hussain R, Khan S ACS Omega. 2024; 9(28):31148-31158.

PMID: 39035878 PMC: 11256303. DOI: 10.1021/acsomega.4c04599.

evaluation on potential inhibitors data: DFT and molecular modelling approaches.

Oyebamiji A, Akintelu S, Adekunle D, Oke D, Olanrewaju A, Akinola O Data Brief. 2024; 55:110565.

PMID: 38952955 PMC: 11214998. DOI: 10.1016/j.dib.2024.110565.

Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)--aryl-4-1,2,4-triazol-3-amine Analogs.

Ahsan M, Gautam K, Ali A, Ali A, Altamimi A, Salahuddin Molecules. 2023; 28(19).

PMID: 37836779 PMC: 10574406. DOI: 10.3390/molecules28196936.

Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents.

Emami L, Sadeghian S, Mojaddami A, Khabnadideh S, Sakhteman A, Sadeghpour H BMC Chem. 2022; 16(1):91.

PMID: 36369166 PMC: 9652805. DOI: 10.1186/s13065-022-00887-x.

References

Porta C, Riboldi E, Sica A . Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett. 2010; 305(2):250-62. DOI: 10.1016/j.canlet.2010.10.012. View

Asami T, Min Y, Nagata N, Yamagishi K, Takatsuto S, Fujioka S . Characterization of brassinazole, a triazole-type brassinosteroid biosynthesis inhibitor. Plant Physiol. 2000; 123(1):93-100. PMC: 58985. DOI: 10.1104/pp.123.1.93. View

Leung-Toung R, Wodzinska J, Li W, Lowrie J, Kukreja R, Desilets D . 1,2,4-thiadiazole: a novel Cathepsin B inhibitor. Bioorg Med Chem. 2003; 11(24):5529-37. DOI: 10.1016/j.bmc.2003.09.040. View

Khan F, Akhtar S, Sheikh M . Cancer treatment - objectives and quality of life issues. Malays J Med Sci. 2012; 12(1):3-5. PMC: 3349406. View

Kumar D, Kumar N, Chang K, Gupta R, Shah K . Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles. Bioorg Med Chem Lett. 2011; 21(19):5897-900. DOI: 10.1016/j.bmcl.2011.07.089. View

El Shehry M, Abu-Hashem A, El-Telbani E . Synthesis of 3-((2,4-dichlorophenoxy)methyl)-1,2,4-triazolo(thiadiazoles and thiadiazines) as anti-inflammatory and molluscicidal agents. Eur J Med Chem. 2010; 45(5):1906-11. DOI: 10.1016/j.ejmech.2010.01.030. View

Maiti A, Reddy P, Sturdy M, Marler L, Pegan S, Mesecar A . Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities. J Med Chem. 2009; 52(7):1873-84. PMC: 2673050. DOI: 10.1021/jm801335z. View

Sreenivasulu R, Reddy K, Sujitha P, Kumar C, Raju R . Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl)hydrazide-hydrazone derivatives. Bioorg Med Chem. 2019; 27(6):1043-1055. DOI: 10.1016/j.bmc.2019.02.002. View

Wittine K, Stipkovic Babic M, Makuc D, Plavec J, Kraljevic Pavelic S, Sedic M . Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations. Bioorg Med Chem. 2012; 20(11):3675-85. DOI: 10.1016/j.bmc.2012.01.054. View

10.

Zhang Q, Peng Y, Wang X, Keenan S, Arora S, Welsh W . Highly potent triazole-based tubulin polymerization inhibitors. J Med Chem. 2007; 50(4):749-54. PMC: 2694353. DOI: 10.1021/jm061142s. View

11.

Zhang S, Xu Z, Gao C, Ren Q, Chang L, Lv Z . Triazole derivatives and their anti-tubercular activity. Eur J Med Chem. 2017; 138:501-513. DOI: 10.1016/j.ejmech.2017.06.051. View

12.

Park S, Cho L, Yang J, Park B, Chang S, Lee K . Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study. Lung Cancer. 2009; 68(1):20-6. DOI: 10.1016/j.lungcan.2009.05.017. View

13.

Mathew V, Keshavayya J, Vaidya V, Giles D . Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues. Eur J Med Chem. 2007; 42(6):823-40. DOI: 10.1016/j.ejmech.2006.12.010. View

14.

Clemens M . Free radicals in chemical carcinogenesis. Klin Wochenschr. 1991; 69(21-23):1123-34. DOI: 10.1007/BF01645172. View

15.

Jin R, Zeng C, Liang X, Sun X, Liu Y, Wang Y . Design, synthesis, biological activities and DFT calculation of novel 1,2,4-triazole Schiff base derivatives. Bioorg Chem. 2018; 80:253-260. DOI: 10.1016/j.bioorg.2018.06.030. View

16.

Unangst P, Shrum G, Connor D, Dyer R, Schrier D . Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors. J Med Chem. 1992; 35(20):3691-8. DOI: 10.1021/jm00098a015. View

17.

Holla B, Poojary K, Sooryanarayana Rao B, Shivananda M . New bis-aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents. Eur J Med Chem. 2002; 37(6):511-7. DOI: 10.1016/s0223-5234(02)01358-2. View

18.

Kapron B, Luszczki J, Plazinska A, Siwek A, Karcz T, Grybos A . Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies. Eur J Pharm Sci. 2018; 129:42-57. DOI: 10.1016/j.ejps.2018.12.018. View

19.

Stresser D, Turner S, McNamara J, Stocker P, Miller V, Crespi C . A high-throughput screen to identify inhibitors of aromatase (CYP19). Anal Biochem. 2000; 284(2):427-30. DOI: 10.1006/abio.2000.4729. View

20.

Rebucci M, Michiels C . Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol. 2013; 85(9):1219-26. DOI: 10.1016/j.bcp.2013.02.017. View